| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.18B | 29.82B | 30.36B | 28.72B | 21.94B | 19.71B |
| Gross Profit | 10.30B | 10.51B | 10.70B | 11.36B | 8.57B | 7.15B |
| EBITDA | 6.09B | 5.29B | 5.15B | 6.41B | 6.39B | 2.59B |
| Net Income | 1.82B | 978.00M | 2.30B | 2.68B | 3.32B | -204.00M |
Balance Sheet | ||||||
| Total Assets | 51.63B | 53.77B | 55.15B | 53.42B | 49.82B | 43.52B |
| Cash, Cash Equivalents and Short-Term Investments | 2.07B | 2.35B | 2.38B | 2.77B | 3.25B | 4.00B |
| Total Debt | 0.00 | 17.05B | 18.24B | 16.38B | 16.87B | 18.20B |
| Total Liabilities | 31.40B | 31.37B | 32.36B | 31.50B | 30.12B | 29.12B |
| Stockholders Equity | 17.71B | 19.58B | 20.06B | 19.55B | 17.36B | 13.39B |
Cash Flow | ||||||
| Free Cash Flow | 2.71B | 3.04B | 1.75B | 2.48B | 2.58B | 1.50B |
| Operating Cash Flow | 5.25B | 5.50B | 4.43B | 4.50B | 4.18B | 3.14B |
| Investing Cash Flow | -2.63B | -2.44B | -3.58B | -2.29B | -2.29B | -1.44B |
| Financing Cash Flow | -2.60B | -2.57B | -816.00M | -3.13B | -2.87B | 1.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $41.38B | 14.39 | 15.97% | 8.22% | -0.68% | 4.29% | |
78 Outperform | $44.70B | 22.51 | 9.49% | 2.04% | -4.32% | 74.30% | |
75 Outperform | $136.03B | 19.04 | 8.97% | 1.83% | -2.06% | 21.03% | |
70 Outperform | $2.60B | 18.21 | 9.07% | 2.53% | 16.59% | 1.72% | |
65 Neutral | $20.95B | 45.37 | 5.48% | 4.33% | 1.44% | -38.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | $9.69B | -4.59 | -17.66% | 4.08% | -4.01% | -339.22% |